In a new study led by scientists at the Wilmer Eye Institute, Johns Hopkins Medicine researchers say they have determined ...

For years, metformin has been the go-to first-line oral medication for patients newly diagnosed with type 2 diabetes. But ...

Two years on from The Royal Gazette’s first report on a new wave of diabetes drugs with broader health benefits, the island’s ...

A recent study reveals that semaglutide, a diabetes medication known for its weight-loss effects, shows promise in treating metabolic dysfunction-associated steatohepatitis (MASH), a common liver ...

A common diabetes drug can reduce the pain of people with knee osteoarthritis and overweight or obesity, possibly delaying ...

The scientists found that two medications significantly reduce the risk of developing dementia in life. A new study, published in JAMA Neurology, finds that people with type 2 diabetes who take ...

Now, a major study published in JAMA Neurology reveals that certain medications used to treat type 2 diabetes might offer significant protection against Alzheimer’s disease and other forms of ...

A common diabetes drug can be repurposed to help overweight and obese people with knee arthritis, a new study says. Metformin reduced knee arthritis pain during a six-month treatment period ...

According to the researchers, the findings indicated that the two drugs may have neuroprotective effects for people without diabetes and may help slow the rate of cognitive decline in Alzheimer's ...

A new study reveals that metformin, a common medication for type 2 diabetes, can significantly reduce pain and stiffness in overweight individuals with knee osteoarthritis (OA).

A partnership between Sequel Med Tech and Senseonics creates the first automated insulin delivery system with a 1-year ...